AIDS 2016: Access to Home Testing Doubles Frequency of HIV Testing Among Australian Gay Men

A randomized trial conducted with Australian gay men has shown that easy access to self-testing kits can double the frequency with which men test for HIV, with an even greater increase among men who used to test infrequently, Muhammad Jamil of the Kirby Institute reported at the 21st International AIDS Conference (AIDS 2016) last month in Durban.


AIDS 2016: HIV Viral Load Pilot Study Shows Roll-Out Will Depend on an Educated Workforce

For viral load testing to prevent HIV treatment failure, drug resistance, and onward transmission, treatment programs will need to invest in better record-keeping and clinic procedures, human resources, demand creation, and decentralization of second-line treatment provision, a large pilot study of viral load test provision in southern Africa has found. Findings were presented last month at the 21st International AIDS Conference (AIDS 2016) in Durban.


AIDS 2016: START Analysis Looks at Who Benefits Most from Immediate HIV Treatment

Starting antiretroviral therapy (ART) soon after HIV diagnosis led to better outcomes than delayed treatment in all population subgroups in the START trial, researchers reported at the 21st International AIDS Conference (AIDS 2016) last week in Durban. But some people saw greater risk reductions, including those over age 50, those with a lower CD4:CD8 ratio and higher viral load, and those with cardiovascular risk factors.


AIDS 2016: HIV Criminalization on the Rise, Especially in Sub-Saharan Africa

Globally, 72 countries have adopted laws that specifically allow for HIV criminalization, either because the law is specific to HIV, or because it names HIV as one (or more) of the diseases covered by a broader law. This total increases to 101 jurisdictions when the HIV criminalization laws in 30 of the states that make up the U.S. are counted individually. The findings were presented at the Beyond Blame pre-conference held in advance of the 21st International AIDS Conference (AIDS 2016) last month in Durban.


AIDS 2016: Starting Treatment on the Day of HIV Diagnosis Improves Outcomes

Interventions to improve linkage to HIV care and retention in treatment which speed up the start of antiretroviral therapy (ART) or provide intensive support to people before starting treatment produce better retention than standard practices, researchers reported at the 21st International AIDS Conference (AIDS 2016) last week in Durban.


Coverage of 21st International AIDS Conference (AIDS 2016) coverage of the 21st International AIDS Conference (AIDS 2016), held July 18-22, in Durban, South Africa.

Conference highlights include PrEP and other biomedical HIV prevention, HIV cure research, experimental antiretroviral therapy, and access to treatment and prevention for key affected populations.

Full listing by topic

AIDS 2016 website



AIDS 2016: PrEP Rollout in France Tops 1000, Ipergay Shows 97% Effectiveness

Through July 2016, a total of 1077 people -- 96.4% of them gay men -- have started HIV pre-exposure prophylaxis (PrEP) through the public healthcare system in France, Jean-Michel Molina, principal investigator of the Ipergay trial, told delegates at the 21st International AIDS Conference (AIDS 2016) last week in Durban. 90 clinics now offer PrEP assessment and prescription, and 273 doctors have been accredited as PrEP physicians.